 |
| |
| Sep-18-18 | Reiterated |
H.C. Wainwright |
Neutral |
$17 → $22 |
|
| Nov-27-17 | Initiated |
H.C. Wainwright |
Buy |
$12 |
|
| Jun-14-16 | Reiterated |
Mizuho |
Buy |
$12 → $8 |
|
| Sep-29-15 | Downgrade |
Raymond James |
Outperform → Mkt Perform |
|
|
| Sep-25-15 | Initiated |
Craig Hallum |
Buy |
|
|
| Mar-18-15 | Reiterated |
Mizuho |
Buy |
$15 → $12 |
|
|
|
| Oct-02-18 08:00AM | CareDx Profiles AlloSeq Suite of NGS Products at ASHI GlobeNewswire -7.91% |
| Sep-21-18 08:00AM | CareDx to Participate in Upcoming Investor Conference GlobeNewswire |
| Sep-18-18 11:10AM | CareDx Inc (NASDAQ:CDNA): Are Analysts Optimistic? Simply Wall St. |
| Sep-17-18 08:00AM | CareDx broadens HeartCare availability GlobeNewswire |
| Sep-07-18 03:57PM | Stock Market Forecast: More Gains, More Volatility Investor's Business Daily |
| Aug-27-18 07:45AM | Edited Transcript of CDNA earnings conference call or presentation 9-Aug-18 8:30pm GMT Thomson Reuters StreetEvents |
| Aug-24-18 08:10AM | Factors of Influence in 2018, Key Indicators and Opportunity within Seres Therapeutics, Barnes & Noble, Carbo Ceramics, BioLife Solutions, CareDx, and Syntel New Research Emphasizes Economic Growth GlobeNewswire |
| Aug-15-18 09:00AM | CareDx to Participate in Upcoming Investor Conference GlobeNewswire |
| Aug-10-18 08:07PM | Here's Why CareDx Jumped 13.5% Today Motley Fool +13.49% |
| 07:38AM | The Daily Biotech Pulse: Puma, CareDx Soar On Earnings, Corcept Plunges On Bottom-Line Miss Benzinga |
| Aug-09-18 07:40PM | CareDX stock soars nearly 20% after earnings MarketWatch |
| 06:00PM | CareDx (CDNA) Reports Q2 Loss, Tops Revenue Estimates Zacks |
| 04:58PM | CareDx: 2Q Earnings Snapshot Associated Press |
| 04:01PM | CareDx Reports Second Quarter Results GlobeNewswire |
| Jul-16-18 08:00AM | CareDx to Announce Second Quarter 2018 Financial Results on August 9, 2018 GlobeNewswire |
| Jun-28-18 08:00AM | Flatiron Health CMO/CSO Joins CareDx Board of Directors GlobeNewswire +5.08% |
| Jun-22-18 02:55PM | Here's Why CareDx Dropped Today Motley Fool -9.45% |
| Jun-21-18 07:40AM | Free Technical Reports on Myriad Genetics and Three Additional Services Equities ACCESSWIRE |
| Jun-19-18 09:00AM | CareDx set to join Russell 2000, Russell 3000 and Russell Microcap Indexes GlobeNewswire |
| 08:10AM | New Research: Key Drivers of Growth for New Mountain Finance, Chicago Rivet & Machine, Caseys General Stores, Great Western, Capstead Mortgage, and CareDx Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire |
| Jun-05-18 08:00AM | CareDx Promotes Living Donor Transplantation Through Employee Policy GlobeNewswire +11.56% |
| Jun-01-18 08:00AM | Key CareDx Events Scheduled at American Transplant Congress 2018 GlobeNewswire |
| May-24-18 08:00AM | CareDx to Hold Press Conference at American Transplant Congress GlobeNewswire |
| May-17-18 05:34PM | Edited Transcript of CDNA earnings conference call or presentation 10-May-18 8:30pm GMT Thomson Reuters StreetEvents |
| May-15-18 12:02PM | Best Growth Stocks To Buy Now Simply Wall St. |
| May-10-18 05:31PM | CareDx: 1Q Earnings Snapshot Associated Press |
| 04:01PM | CareDx Reports First Quarter Results GlobeNewswire |
| May-09-18 08:00AM | CareDx expands NGS Transplant Product Offerings GlobeNewswire |
| May-01-18 08:00AM | CareDx Activities at American Transplant Congress GlobeNewswire +5.11% |
| Apr-25-18 07:40AM | Free Post Earnings Research Report: CareDxs Quarterly Sales Rose 15%; Adjusted Net Loss Narrowed ACCESSWIRE |
| Apr-20-18 08:00AM | CareDx to Announce First Quarter 2018 Financial Results on May 10, 2018 GlobeNewswire |
| Apr-18-18 08:00AM | CareDx Closes Debt Refinancing GlobeNewswire |
| Apr-13-18 08:00AM | Olerup QTYPE® Receives CE Mark Certification GlobeNewswire |
| Apr-10-18 08:00AM | CareDx Launches HeartCare® for Heart Transplant Recipients GlobeNewswire |
| Apr-04-18 07:00AM | Wired News Myriad Genetics Receives Japanese Regulatory Approval for BRACAnalysis(R) Diagnostic System ACCESSWIRE +6.12% |
| Mar-29-18 08:00AM | CareDx Announces Completion of Debt Conversion GlobeNewswire |
| Mar-23-18 07:11PM | Edited Transcript of CDNA earnings conference call or presentation 22-Mar-18 8:30pm GMT Thomson Reuters StreetEvents +25.75% |
| Mar-22-18 04:42PM | CareDx reports 4Q loss Associated Press |
| 04:01PM | CareDx Reports Fourth Quarter and FY2017 Financial Results GlobeNewswire |
| 12:00PM | CareDx, Inc. to Host Earnings Call ACCESSWIRE |
| Mar-06-18 08:00AM | CareDx to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on March 22, 2018 GlobeNewswire |
| Mar-01-18 07:30AM | CareDx to Refinance Debt with Perceptive Advisors GlobeNewswire |
| Feb-27-18 08:25AM | Analysis: Positioning to Benefit within AZZ, Brink's, CareDx, Kinsale Capital Group, Wingstop, and Ambac Financial Group Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire |
| Feb-07-18 08:00AM | CareDx to Participate in Upcoming Investor Conferences GlobeNewswire |
| Feb-05-18 09:00AM | CareDx Leadership in cfDNA Highlighted at CEoT GlobeNewswire |
| Feb-01-18 08:00AM | First Patient Enrolled in AlloSure Registry GlobeNewswire |
| Jan-16-18 09:00AM | TRIO Honors Peter Maag with Transplant Innovation Award GlobeNewswire -8.02% |
| Jan-08-18 08:30AM | CareDx Reports Preliminary Fourth Quarter and FY2017 Financial Results GlobeNewswire |
| Dec-29-17 10:44AM | CORRECTING and REPLACING - Market Trends Toward New Normal in MDU Resources Group, TerraForm Global, CareDx, Kinsale Capital Group, UMB Financial, and Greif Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
| Dec-28-17 12:04PM | CORRECTING and REPLACING - Market Trends Toward New Normal in MDU Resources Group, TerraForm Global, CareDx, Kinsale Capital Group, UMB Financial, and Greif Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
| 08:00AM | Market Trends Toward New Normal in MDU Resources Group, TerraForm Global, CareDx, Kinsale Capital Group, UMB Financial, and Greif Bros. Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
| Dec-11-17 10:13AM | Here's Why You Should Steer Clear of LifePoint (LPNT) Stock Zacks |
| Dec-07-17 09:26AM | The Zacks Analyst Blog Highlights: Aetna, CareDx, PRA Health Sciences and Diplomat Pharmacy Zacks |
| Dec-06-17 01:07PM | 4 Attractive Stocks to Buy in an Evolving Healthcare Space Zacks |
| Dec-01-17 09:02AM | The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx Zacks |
| Nov-30-17 02:54PM | 4 Top-Ranked Growth Stocks in MedTech Under $20 Zacks |
| Nov-27-17 12:38PM | ETFs with exposure to CareDx, Inc. : November 27, 2017 Capital Cube +10.00% |
| Nov-20-17 08:00AM | CMS Releases 2018 Clinical Laboratory Fee Schedule GlobeNewswire |
| Nov-17-17 11:33AM | ETFs with exposure to CareDx, Inc. : November 17, 2017 Capital Cube |
| Nov-16-17 12:31AM | Edited Transcript of CDNA earnings conference call or presentation 9-Nov-17 9:30pm GMT Thomson Reuters StreetEvents |
| Nov-15-17 09:00AM | CareDx Further Simplifies its Balance Sheet GlobeNewswire |
| 08:49AM | Teladoc Rides on Growing Demand for Telehealth Services Zacks |
| Nov-13-17 09:21AM | CareDx, Inc. :CDNA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017 Capital Cube |
| Nov-09-17 04:16PM | CareDx reports 3Q loss Associated Press |
| 04:02PM | CareDx Reports Third Quarter 2017 Financial Results GlobeNewswire |
| 12:30PM | CareDx, Inc. to Host Earnings Call ACCESSWIRE |
| Nov-07-17 09:54AM | ETFs with exposure to CareDx, Inc. : November 7, 2017 Capital Cube |
| Nov-02-17 09:00AM | CareDx to Participate in Upcoming Investor Conferences GlobeNewswire |
| Oct-31-17 09:00AM | CareDx Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire |
| Oct-30-17 08:00AM | AlloSure data will be presented at ASN GlobeNewswire |
| Oct-27-17 09:00AM | CareDx to Announce Third Quarter 2017 Financial Results on November 9, 2017 GlobeNewswire |
| Oct-10-17 04:00PM | CareDx Announces Closing of Public Offering of Common Stock GlobeNewswire |
| 11:08AM | ETFs with exposure to CareDx, Inc. : October 10, 2017 Capital Cube |
| Oct-05-17 07:45PM | How Does CareDx Inc (CDNA) Affect Your Portfolio Returns? Simply Wall St. +31.97% |
| Sep-26-17 08:30AM | MolDX sets AlloSure reimbursement at 2017 AlloMap level GlobeNewswire +23.72% |
| Sep-25-17 10:35AM | ETFs with exposure to CareDx, Inc. : September 25, 2017 Capital Cube +8.12% |
| Sep-22-17 05:26PM | AlloMaps Medicare reimbursement to increase in 2018 GlobeNewswire |
| Sep-21-17 06:51PM | Have Investors Already Priced In CareDx Incs (CDNA) Growth? Simply Wall St. |
| 01:41PM | This Market Knows No Fear TheStreet.com |
| Sep-14-17 06:04PM | ETFs with exposure to CareDx, Inc. : September 14, 2017 Capital Cube |
| Sep-13-17 11:28AM | CareDx, Inc. :CDNA-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017 Capital Cube |
| Aug-24-17 01:05PM | CareDx Confirms AlloSure Will Receive Medicare Coverage Effective October 9th, 2017 GlobeNewswire +33.02% |
| Aug-17-17 07:50AM | Edited Transcript of CDNA earnings conference call or presentation 10-Aug-17 8:30pm GMT Thomson Reuters StreetEvents |
| Aug-15-17 08:00AM | CareDx to Participate in Upcoming Investor Conferences GlobeNewswire +5.26% |
| Aug-10-17 09:43PM | CareDx reports 2Q loss Associated Press -5.63% |
| 04:43PM | CareDx reports 2Q loss Associated Press |
| 04:01PM | CareDx Reports Second Quarter 2017 Financial Results GlobeNewswire |
| 03:30PM | Investor Network: CareDx, Inc. to Host Earnings Call ACCESSWIRE |
| Aug-04-17 03:00PM | CareDx Describes Extensive Analytical Validation Data on AlloSure Robustness at American Association of Clinical Chemistry Annual Meeting GlobeNewswire |
| Jul-27-17 08:00AM | CareDx to Announce Second Quarter 2017 Financial Results on August 10, 2017 GlobeNewswire |
| Jul-13-17 08:00AM | 100,000th AlloMap Result Provided to Heart Transplant Patients GlobeNewswire |
| Jul-10-17 02:08PM | ETFs with exposure to CareDx, Inc. : July 10, 2017 Capital Cube +28.00% |
| Jul-03-17 08:30AM | CareDx Restructures and Defers Certain Obligations to March 2019 GlobeNewswire |
| Jun-28-17 02:38PM | ETFs with exposure to CareDx, Inc. : June 28, 2017 Capital Cube |
| Jun-16-17 03:31PM | ETFs with exposure to CareDx, Inc. : June 16, 2017 Capital Cube |
| Jun-14-17 09:24AM | CareDx, Inc. :CDNA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube |
| Jun-09-17 09:04AM | CareDx reports 1Q loss Associated Press |
| 08:30AM | CareDx Reports First Quarter 2017 Financial Results GlobeNewswire |
| May-30-17 08:00AM | CareDx Activities at European Federation of Immunogenetics Congress GlobeNewswire |
| May-26-17 07:28AM | What's in the Cards for Box, Inc (BOX) in Q1 Earnings? Zacks |
|
|
|
|
| CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, engages in the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients worldwide. It operates through two segments, Post-Transplant Diagnostics and Pre-Transplant Diagnostics. The Post-Transplant Diagnostics segment develops and provides a diagnostic surveillance testing solution for heart and kidney transplant recipients. It offers AlloMap, a heart transplant molecular test; and AlloSure, a donor-derived cell free DNA test initially used for kidney transplant patients. The Pre-Transplant Diagnostics segment develops, manufactures, markets, and sells products that increase the chance of successful transplants by facilitating a match between a donor and a recipient of stem cells and organs. It sells Olerup SSP, which is used to type human leukocyte antigen (HAL) alleles based on sequence-specific primer technology; Olerup QTYPE, a test kit for sequence based HLA typing; Olerup SBT, a test kit for sequence based HLA typing; and XM-ONE, a test that identifies a patient's antigens against HLA Class I or Class II, as well as antibodies against a donor's endothelium. This segment offers its products directly to customers, as well as through third-party distributors. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in Brisbane, California. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| King Sasha | Chief Commercial Officer | Oct 05 | Sale | 24.60 | 11,500 | 282,900 | 53,542 | Oct 09 07:23 PM | | Bell Michael Brian | Chief Financial Officer | Sep 13 | Sale | 25.06 | 16,355 | 409,920 | 52,238 | Sep 13 08:26 PM | | Maag Peter | See Remarks | Sep 04 | Sale | 23.10 | 15,000 | 346,542 | 439,747 | Sep 04 09:25 PM | | Cohen Fred E | Director | Aug 28 | Option Exercise | 1.22 | 15,000 | 18,300 | 52,901 | Aug 29 06:09 PM | | Bell Michael Brian | Chief Financial Officer | Aug 14 | Sale | 16.84 | 12,500 | 210,463 | 68,593 | Aug 14 04:41 PM | | King Sasha | Chief Commercial Officer | Aug 01 | Option Exercise | 1.03 | 6,458 | 6,648 | 74,500 | Aug 01 07:32 PM | | King Sasha | Chief Commercial Officer | Aug 01 | Sale | 14.03 | 9,458 | 132,735 | 65,042 | Aug 01 07:32 PM | | Nelles Mitchell J | Chief Operating Officer | Jul 02 | Option Exercise | 4.25 | 31,899 | 135,649 | 126,538 | Jul 03 05:43 PM | | Nelles Mitchell J | Chief Operating Officer | Jul 02 | Sale | 12.48 | 39,649 | 494,911 | 86,889 | Jul 03 05:43 PM | | GAGNON NEIL | 10% Owner | Apr 26 | Buy | 9.42 | 10,136 | 95,481 | 965,894 | Apr 30 05:48 PM | | Maag Peter | See Remarks | Mar 27 | Sale | 7.87 | 15,000 | 118,035 | 272,037 | Mar 28 04:46 PM | | Maag Peter | See Remarks | Mar 20 | Option Exercise | 0.55 | 50,000 | 27,400 | 287,037 | Mar 21 06:00 PM | | Yee James P | Chief Medical Officer | Dec 08 | Option Exercise | 3.36 | 29,197 | 98,000 | 74,795 | Dec 08 07:59 PM | | Yee James P | Chief Medical Officer | Dec 08 | Sale | 7.00 | 29,197 | 204,379 | 45,598 | Dec 08 07:59 PM | | Nelles Mitchell J | Chief Operating Officer | Nov 30 | Option Exercise | 3.36 | 10,948 | 36,785 | 84,225 | Nov 30 09:23 PM | | Nelles Mitchell J | Chief Operating Officer | Nov 30 | Sale | 7.17 | 10,948 | 78,487 | 73,277 | Nov 30 09:23 PM |
|
|
|
|
|
|
